TD Asset Management Inc trimmed its position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 45.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,144 shares of the technology company’s stock after selling 6,692 shares during the quarter. TD Asset Management Inc’s holdings in Novanta were worth $816,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. AQR Capital Management LLC raised its position in Novanta by 78.9% during the first quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company’s stock valued at $537,000 after acquiring an additional 1,866 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Novanta by 1.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company’s stock valued at $53,582,000 after purchasing an additional 6,533 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of Novanta by 1,762.5% in the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company’s stock valued at $7,881,000 after purchasing an additional 58,322 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in Novanta by 11.3% in the second quarter. Envestnet Asset Management Inc. now owns 70,795 shares of the technology company’s stock worth $9,128,000 after purchasing an additional 7,216 shares in the last quarter. Finally, Atria Investments Inc raised its holdings in Novanta by 11.2% during the second quarter. Atria Investments Inc now owns 3,031 shares of the technology company’s stock valued at $391,000 after buying an additional 305 shares in the last quarter. Institutional investors own 98.35% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on NOVT shares. Weiss Ratings upgraded Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, January 20th. Robert W. Baird set a $150.00 price target on Novanta in a report on Wednesday, February 25th. Finally, Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a research note on Friday, January 16th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Novanta presently has an average rating of “Hold” and an average target price of $150.00.
Insider Transactions at Novanta
In related news, CFO Robert Buckley sold 1,423 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $140.88, for a total transaction of $200,472.24. Following the sale, the chief financial officer owned 93,814 shares in the company, valued at approximately $13,216,516.32. This represents a 1.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total value of $1,087,800.00. Following the transaction, the chief executive officer directly owned 57,367 shares of the company’s stock, valued at $8,320,509.68. This trade represents a 11.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 24,346 shares of company stock valued at $3,382,737. Company insiders own 1.20% of the company’s stock.
Novanta Price Performance
NASDAQ NOVT opened at $131.22 on Friday. The firm’s 50 day moving average is $134.88 and its 200-day moving average is $121.00. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. The company has a market capitalization of $4.68 billion, a PE ratio of 89.88 and a beta of 1.61. Novanta Inc. has a 12-month low of $98.27 and a 12-month high of $149.95.
Novanta (NASDAQ:NOVT – Get Free Report) last released its earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The business had revenue of $258.35 million during the quarter, compared to the consensus estimate of $260.72 million. During the same quarter last year, the firm earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. Equities research analysts anticipate that Novanta Inc. will post 3.03 earnings per share for the current fiscal year.
Novanta Company Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Featured Stories
- Five stocks we like better than Novanta
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
